Type I CRISPR-Cas-mediated microbial gene editing and regulation

• Published in: AIMS microbiology Vol. 9; no. 4; pp. 780 - 800
• Main Authors: Xu, Zeling, Chen, Shuzhen, Wu, Weiyan, Wen, Yongqi, Cao, Huiluo
• Format: Journal Article
• Language: English
• Published: United States AIMS Press 01-01-2023
• Subjects: anti-crispr; cascade; crispr-cas; gene activation; gene editing; gene repression; Review; gene repression; CRISPR-Cas; anti-CRISPR; gene activation; gene editing; Cascade
• ISSN: 2471-1888; 2471-1888
• DOI: 10.3934/microbiol.2023040

There are six major types of CRISPR-Cas systems that provide adaptive immunity in bacteria and archaea against invasive genetic elements. The discovery of CRISPR-Cas systems has revolutionized the field of genetics in many organisms. In the past few years, exploitations of the most abundant class 1 type I CRISPR-Cas systems have revealed their great potential and distinct advantages to achieve gene editing and regulation in diverse microorganisms in spite of their complicated structures. The widespread and diversified type I CRISPR-Cas systems are becoming increasingly attractive for the development of new biotechnological tools, especially in genetically recalcitrant microbial strains. In this review article, we comprehensively summarize recent advancements in microbial gene editing and regulation by utilizing type I CRISPR-Cas systems. Importantly, to expand the microbial host range of type I CRISPR-Cas-based applications, these structurally complicated systems have been improved as transferable gene-editing tools with efficient delivery methods for stable expression of CRISPR-Cas elements, as well as convenient gene-regulation tools with the prevention of DNA cleavage by obviating deletion or mutation of the Cas3 nuclease. We envision that type I CRISPR-Cas systems will largely expand the biotechnological toolbox for microbes with medical, environmental and industrial importance.